Zenith Drugs shareholders and shareholding pattern
NSE: ZENITHDRUGPharmaceuticals & Biotechnology
Last close ₹39.45up ₹1.25 (3.27%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹38.20.
52-week range of traded prices to 23 Oct 2026
₹33.30Low, 30 Mar 2026₹65.50High, 24 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹68 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 15 Jun 2026
- 17.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 15 Jun 2026
- 0.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 15 Jun 2026
- 5.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 15 Jun 2026
- 0.75
- Volume, NSEVolume. Shares traded on the last trading day.
- 3,200
Who owns Zenith Drugs, filing by filing
Per cent of the company's shares. Every filing on record, from Mar 2024; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters69.98%
- Foreign institutionsNone
- Indian institutionsNone
- Individuals and others30.02%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Mar 2024Filed 20 Apr | Sep 2024Filed 8 Oct | Mar 2025Filed 12 Apr | Sep 2025Filed 16 Oct | Mar 2026Filed 20 Apr | Sep 2026Filed 16 Oct |
|---|---|---|---|---|---|---|
| 69.98% | 69.98% | 69.98% | 69.98% | 69.98% | 69.98% | |
| Indian promoters | 69.98% | 69.98% | 69.98% | 69.98% | 69.98% | 69.98% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 30.02% | 30.02% | 30.02% | 30.02% | 30.02% | 30.02% |
| Shares in issue | 1,71,48,800 | 1,71,48,800 | 1,71,48,800 | 1,71,48,800 | 1,71,48,800 | 1,71,48,800 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 1,26,44,800 | 1,20,00,000 | 1,20,00,000 | 34,32,000 | 34,32,000 | 1,09,89,960 |
| Promoters' shares locked in | 1,20,00,000 | 1,20,00,000 | 1,20,00,000 | 34,32,000 | 34,32,000 | 1,09,89,960 |
A dash is a line the filing did not state.
Zenith Drugs promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is AJAY SINGH DASSUNDI, 22.52%.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| AJAY SINGH DASSUNDIIndividuals and Hindu undivided families | 22.52% | 38,61,990 | 100.00% |
| SANDEEP BHARDWAJIndividuals and Hindu undivided families | 21.38% | 36,66,990 | 100.00% |
| BHUPESH SONIIndividuals and Hindu undivided families | 20.18% | 34,60,980 | 100.00% |
| JAYWANTI SONIIndividuals and Hindu undivided families | 2.94% | 5,04,000 | 0.00% |
| PRIYANKA BHARADWAJIndividuals and Hindu undivided families | 1.94% | 3,33,000 | 0.00% |
| ANJALI DASSUNDIIndividuals and Hindu undivided families | 0.80% | 1,38,000 | 0.00% |
| SAROJ SONIIndividuals and Hindu undivided families | 0.20% | 35,040 | 0.00% |
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of Zenith Drugs, filing by filing
Per cent, on the same shares as the split above.
| Holder | Mar 2024Filed 20 Apr | Sep 2024Filed 8 Oct | Mar 2025Filed 12 Apr | Sep 2025Filed 16 Oct | Mar 2026Filed 20 Apr | Sep 2026Filed 16 Oct |
|---|---|---|---|---|---|---|
| AMIT GARGResident individuals, over ₹2 lakh at face value | – | 1.06% | 1.46% | 2.00% | – | – |
| BINDU GARGResident individuals, over ₹2 lakh at face value | – | – | – | 1.04% | – | – |
| GRETEX SHARE BROKING LIMITEDCompanies | 3.47% | 1.19% | 1.23% | – | – | – |
| PRAVEEN MUDUNURIResident individuals, over ₹2 lakh at face value | 1.11% | 1.21% | 1.22% | – | – | – |
| MERU INVESTMENT FUND PCC-CELL 1Foreign portfolio investors, category I | 2.20% | – | – | – | – | – |
| ARIES OPPORTUNITIES FUND LIMITEDForeign portfolio investors, category I | 1.47% | – | – | – | – | – |
| VIKASA INDIA EIF I FUND - ZODIAC GLOBAL OPPORTUNITY FUNDForeign portfolio investors, category I | 1.23% | – | – | – | – | – |
| YUGA STOCKS AND COMMODITIES PRIVATE LIMITEDCompanies | 1.17% | – | – | – | – | – |
| NEOMILE GROWTH FUND - SERIES IAlternative investment funds | 1.11% | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.